Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research, 13928 [2020-04831]

Download as PDF 13928 Federal Register / Vol. 85, No. 47 / Tuesday, March 10, 2020 / Notices Drug Enforcement Administration [Docket No. DEA–579] Bulk Manufacturer of Controlled Substances Application: Sigma Aldrich Research ACTION: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 11, 2020. DATES: DEPARTMENT OF JUSTICE Notice of application. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 ADDRESSES: Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on December 13, 2019, Sigma Aldrich Research, Biochemicals, Inc., 400–600 Summit Drive, Burlington, Massachusetts 01803 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: Controlled substance Drug code Cathinone ........................................................................................................................................................................ Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... Lysergic acid diethylamide .............................................................................................................................................. Tetrahydrocannabinols .................................................................................................................................................... 3,4-Methylenedioxymethamphetamine ............................................................................................................................ Alpha-methyltryptamine ................................................................................................................................................... Dimethyltryptamine .......................................................................................................................................................... 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. N-Benzylpiperazine .......................................................................................................................................................... 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H) ................................................................................................................. MDPV (3,4-Methylenedioxypyrovalerone) ....................................................................................................................... Methylone (3,4-Methylenedioxy-N-methylcathinone) ...................................................................................................... Heroin .............................................................................................................................................................................. Normorphine .................................................................................................................................................................... Norlevorphanol ................................................................................................................................................................ Amphetamine ................................................................................................................................................................... Nabilone ........................................................................................................................................................................... Phencyclidine ................................................................................................................................................................... Cocaine ............................................................................................................................................................................ Codeine ........................................................................................................................................................................... Ecgonine .......................................................................................................................................................................... Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Methadone ....................................................................................................................................................................... Morphine .......................................................................................................................................................................... Thebaine .......................................................................................................................................................................... Levo-alphacetylmethadol ................................................................................................................................................. Noroxymorphone ............................................................................................................................................................. Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... The company plans to manufacture small quantities of the listed controlled substances to make reference standards for distribution to its customers. Dated: February 10, 2020. William T. McDermott, Assistant Administrator. [FR Doc. 2020–04831 Filed 3–9–20; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration khammond on DSKJM1Z7X2PROD with NOTICES [Docket No. DEA–583] Bulk Manufacturer of Controlled Substances Application: Siemens Healthcare Diagnostics Inc. ACTION: Notice of application. VerDate Sep<11>2014 17:20 Mar 09, 2020 Jkt 250001 Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 11, 2020. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on December 10, 2019, Siemens Healthcare Diagnostics Inc., 100 GBC Drive, Mailstop 514, Newark, Delaware 19702–2461 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: DATES: PO 00000 Frm 00072 Fmt 4703 Sfmt 4703 Controlled substance 1235 1248 7315 7370 7405 7432 7435 7439 7493 7517 7535 7540 9200 9313 9634 1100 7379 7471 9041 9050 9180 9220 9230 9250 9300 9333 9648 9668 9739 9740 9743 9801 Drug code Ecgonine ................... 9180 Schedule I I I I I I I I I I I I I I I II II II II II II II II II II II II II II II II II Schedule II The company plans to produce the listed controlled substance in bulk to be used in the manufacture of DEA exempt products. Dated: February 11, 2020. William T. McDermott, Assistant Administrator. [FR Doc. 2020–04832 Filed 3–9–20; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\10MRN1.SGM 10MRN1

Agencies

[Federal Register Volume 85, Number 47 (Tuesday, March 10, 2020)]
[Notices]
[Page 13928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04831]



[[Page 13928]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-579]


Bulk Manufacturer of Controlled Substances Application: Sigma 
Aldrich Research

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before May 11, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on December 13, 2019, Sigma Aldrich Research, 
Biochemicals, Inc., 400-600 Summit Drive, Burlington, Massachusetts 
01803 applied to be registered as a bulk manufacturer of the following 
basic class(es) of controlled substances:

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
Cathinone..........................            1235  I
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
Lysergic acid diethylamide.........            7315  I
Tetrahydrocannabinols..............            7370  I
3,4-Methylenedioxymethamphetamine..            7405  I
Alpha-methyltryptamine.............            7432  I
Dimethyltryptamine.................            7435  I
5-Methoxy-N,N-diisopropyltryptamine            7439  I
N-Benzylpiperazine.................            7493  I
2-(2,5-Dimethoxyphenyl) ethanamine             7517  I
 (2C-H).
MDPV (3,4-                                     7535  I
 Methylenedioxypyrovalerone).
Methylone (3,4-Methylenedioxy-N-               7540  I
 methylcathinone).
Heroin.............................            9200  I
Normorphine........................            9313  I
Norlevorphanol.....................            9634  I
Amphetamine........................            1100  II
Nabilone...........................            7379  II
Phencyclidine......................            7471  II
Cocaine............................            9041  II
Codeine............................            9050  II
Ecgonine...........................            9180  II
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Methadone..........................            9250  II
Morphine...........................            9300  II
Thebaine...........................            9333  II
Levo-alphacetylmethadol............            9648  II
Noroxymorphone.....................            9668  II
Remifentanil.......................            9739  II
Sufentanil.........................            9740  II
Carfentanil........................            9743  II
Fentanyl...........................            9801  II
------------------------------------------------------------------------

    The company plans to manufacture small quantities of the listed 
controlled substances to make reference standards for distribution to 
its customers.

    Dated: February 10, 2020.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-04831 Filed 3-9-20; 8:45 am]
 BILLING CODE 4410-09-P